Alvotech (ALVO) Consolidated Net Income (2021 - 2026)
Alvotech's (ALVO) quarterly Consolidated Net Income came in at $123000.0 in Q1 2026, down 99.9% YoY from $126.2 million in Q1 2025, and down 99.96% on a QoQ basis from $299.9 million in Q4 2025.
Alvotech (ALVO) Consolidated Net Income (2021 - 2026) Analysis & Trends
Alvotech (ALVO) has 6 years of Consolidated Net Income data on file, last reported at $123000.0 in Q1 2026.
- Quarterly Consolidated Net Income fell 99.9% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $50.1 million (up 119.86% YoY) and the FY2025 annual result came in at $27.9 million, up 111.31% from the prior year.
- Consolidated Net Income slipped to $123000.0 in Q1 2026, from $299.9 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $299.9 million in Q4 2025 to a low of -$651.1 million in Q4 2023.
- A 5-year average of -$77.7 million and a median of -$246152.0 in 2023 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income tumbled 362.17% — and 2025, when it surged 59308.58%.
- Tracing ALVO's Consolidated Net Income over 5 years: stood at -$540.7 million in 2022, then declined by 20.43% to -$651.1 million in 2023, then surged by 65.69% to -$223.4 million in 2024, then surged by 234.25% to $299.9 million in 2025, then tumbled by 99.96% to $123000.0 in 2026.
- The last three Consolidated Net Income figures came in at $123000.0 (Q1 2026), $299.9 million (Q4 2025), and -$307.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alvotech | 1.18 Bn | 1.18 Bn | 5.09 Mn | 942,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123,000.00 |
| Dec 31, 2025 | 299.90 Mn |
| Sep 30, 2025 | -307.87 Mn |
| Jun 30, 2025 | 57.96 Mn |
| Mar 31, 2025 | 126.18 Mn |
| Dec 31, 2024 | -223.39 Mn |
| Sep 30, 2024 | -303.58 Mn |
| Jun 30, 2024 | 148.46 Mn |
| Mar 31, 2024 | -213,111.00 |
| Dec 31, 2023 | -651.14 Mn |
| Aug 31, 2023 | -86.85 Mn |
| Jun 30, 2023 | 138.48 Mn |
| Mar 31, 2023 | -246,152.00 |
| Dec 31, 2022 | -540.69 Mn |
| Aug 31, 2022 | -184.47 Mn |
| Jun 30, 2022 | 264.69 Mn |
| Mar 31, 2022 | -58.90 Mn |
| Dec 31, 2021 | 206.23 Mn |
| Sep 30, 2021 | -33.79 Mn |